Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management
Johnson & Johnson
Manufacturer / labJohnson & Johnson
Product / familyAcuvue Abiliti
DesignReverse-geometry overnight corneal reshaping lens, FDA-approved specifically for slowing myopia progression in children. Also available as Abiliti Overnight for Astigmatism
Corrects / indicated forMyopia progression control in children (FDA indication) with the daytime benefit of spectacle independence
Materialhyper-Dk fluoro silicone acrylate (Menicon-manufactured)
Dk100 ×10⁻¹¹ (material)
Overall diameter10.5 & 11.0 mm
Optic zonetreatment zone optimised for peripheral myopic defocus
Centre thickness~0.24 mm
Power rangemyopia -0.75 to -6.00 D, astigmatism up to -1.50 D (label; expanded from -4.00 D to -6.00 D in Sept 2022)
Wear scheduleovernight
ReplacementAnnually
Fitting approachEmpirical fit from Ks, refraction, HVID and eccentricity via the FitAbiliti software; verify centration and treatment-zone size on morning topography.
First ortho-K lens with an explicit FDA myopia-management indication (approved May 2021). Developed by Johnson & Johnson Vision in collaboration with Menicon. Pairs with the Acuvue Abiliti 1-Day soft lens as the same programme's daily option.
Verify parameters against current manufacturer documentation before fitting.